186
Participants
Start Date
February 28, 2013
Primary Completion Date
June 30, 2018
Study Completion Date
March 31, 2024
Abatacept
Arm B-investigational prophylaxis with abatacept, a calcineurin inhibitor and methotrexate
placebo
Children's National Medical Center, Washington D.C.
Children's Healthcare of Atlanta at Egleston, Atlanta
Emory University/Winship Cancer Center, Atlanta
University of Florida, Gainesville
Michael Grimley, Cincinnati
University of Michigan, Ann Arbor
Washington University, St Louis
Children's Hospital Colorado, Aurora
University of Utah, Salt Lake City
Children's Hospital Los Angeles, Los Angeles
UCSF Benioff Children's Hospital Oakland, Oakland
Seattle Cancer Care Alliance, Seattle
Dana-Farber Cancer Institute, Boston
Children's and Women's Health Center of BC, Vancouver
FDA Office of Orphan Products Development
FED
Boston Children's Hospital
OTHER